Using in silico analysis, we further showed that MCT4 was significantly overexpressed in WHO grade IV GBM compared to WHO grade III anaplastic and WHO grade II diffuse astrocytoma. This evidence concerns the gene SLC16A3 and diffuse astrocytoma.